[go: up one dir, main page]

NO20011537L - Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes - Google Patents

Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes

Info

Publication number
NO20011537L
NO20011537L NO20011537A NO20011537A NO20011537L NO 20011537 L NO20011537 L NO 20011537L NO 20011537 A NO20011537 A NO 20011537A NO 20011537 A NO20011537 A NO 20011537A NO 20011537 L NO20011537 L NO 20011537L
Authority
NO
Norway
Prior art keywords
prevention
treatment
chemokine receptor
diabetes
peptide vaccines
Prior art date
Application number
NO20011537A
Other languages
English (en)
Other versions
NO20011537D0 (no
Inventor
Maureen Howard
Shrikant Deshpande
Walter Ferlin
Subhashini Arimilli
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO20011537D0 publication Critical patent/NO20011537D0/no
Publication of NO20011537L publication Critical patent/NO20011537L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer immunogene oligopeptider avledet fra chemokin-reseptorproteinet for anvendelse i sammensetninger og fremgangsmåter for behandling, og forebygging av inflammatoriske responser.
NO20011537A 1998-09-30 2001-03-26 Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes NO20011537L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/164,186 US6171590B1 (en) 1998-09-30 1998-09-30 Chemokine receptor peptide for inducing an immune response
PCT/US1999/022992 WO2000018431A1 (en) 1998-09-30 1999-09-30 Chemokine receptor peptide vaccines for treatment and prevention of diabetes

Publications (2)

Publication Number Publication Date
NO20011537D0 NO20011537D0 (no) 2001-03-26
NO20011537L true NO20011537L (no) 2001-05-28

Family

ID=22593363

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011537A NO20011537L (no) 1998-09-30 2001-03-26 Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes

Country Status (10)

Country Link
US (2) US6171590B1 (no)
EP (1) EP1117429A4 (no)
JP (1) JP2002525338A (no)
KR (1) KR20010082217A (no)
CN (1) CN1328470A (no)
AU (1) AU6285399A (no)
CA (1) CA2345978A1 (no)
IL (1) IL142283A0 (no)
NO (1) NO20011537L (no)
WO (1) WO2000018431A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000506365A (ja) * 1996-01-11 2000-05-30 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド ヒトｇタンパク質ケモカインレセプターｈｓａｔｕ６８
US7888466B2 (en) * 1996-01-11 2011-02-15 Human Genome Sciences, Inc. Human G-protein chemokine receptor HSATU68
US6140064A (en) * 1996-09-10 2000-10-31 Theodor-Kocher Institute Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3
WO2001072334A2 (en) * 2000-03-27 2001-10-04 Corixa Corporation Methods for treating disease with antibodies to cxcr3
FR2817260A1 (fr) * 2000-11-29 2002-05-31 Centre Nat Rech Scient Peptides ayant des proprietes anti-inflammatoires, leurs utilisations et les compositions les contenant
US20050250175A1 (en) * 2002-08-02 2005-11-10 Takehiko Nomura Bacterial cell wall skeleton component preparaion
JP4452839B2 (ja) * 2004-03-09 2010-04-21 国立大学法人京都大学 Ｃｘｃｒ３阻害剤を含有する医薬組成物
JP5041279B2 (ja) * 2004-04-22 2012-10-03 株式会社 Ｍｂｒ 細菌細胞壁骨格成分を含有する製剤
JP2010521413A (ja) 2006-03-16 2010-06-24 プロタゴニスツ リミテッド 免疫系機能を改変するためのサイトカインとサイトカイン受容体の組合せ
CN100450552C (zh) * 2006-05-26 2009-01-14 中国医学科学院医学生物学研究所 Ⅰ型糖尿病疫苗及其构建方法
US12072338B2 (en) * 2007-03-18 2024-08-27 Protagonists Ltd. Pharmaceutical peptides for the treatment of inflammatory diseases
EP2164508B1 (en) 2007-06-04 2014-01-08 Rappaport Family Institute for Research in the Medical Sciences Agents for the treatment of inflammatory diseases and methods of using same
WO2010103517A1 (en) * 2009-03-12 2010-09-16 Rappaport Family Institute For Research In The Medical Sciences Soluble compositions for the treatment of cxcr3-ligand associated diseases
WO2014186842A1 (en) * 2013-05-22 2014-11-27 Monash University Antibodies and uses thereof
TW201718851A (zh) * 2015-09-18 2017-06-01 通用醫院公司 具有抗化學排斥(anti-fugetactic)性質之經修飾自然殺手細胞及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537764B1 (en) * 1995-01-19 2003-03-25 Children's Medical Center Corporation Method of identifying inhibitors of C—C chemokine receptor 3
AU4898496A (en) 1996-01-11 1997-08-01 Human Genome Sciences, Inc. Human g-protein chemokine receptor hsatu68
ATE360689T1 (de) 1996-09-10 2007-05-15 Kocher Theodor Inst Cxcr3 chemokine rezeptor, antikoerper, nukleinsaeure und deren verfahren zur anwendung
US6528625B1 (en) * 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same
SE9801098D0 (sv) 1998-03-30 1998-03-30 Astra Pharma Prod Receptors

Also Published As

Publication number Publication date
EP1117429A4 (en) 2002-11-20
CN1328470A (zh) 2001-12-26
JP2002525338A (ja) 2002-08-13
NO20011537D0 (no) 2001-03-26
WO2000018431A1 (en) 2000-04-06
KR20010082217A (ko) 2001-08-29
EP1117429A1 (en) 2001-07-25
CA2345978A1 (en) 2000-04-06
IL142283A0 (en) 2002-03-10
AU6285399A (en) 2000-04-17
US6171590B1 (en) 2001-01-09
US20010006942A1 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
MX339406B (es) Antigenos de neisseria meningitidis y composiciones que los contienen.
NO20011537L (no) Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes
DK1353689T3 (da) Immuniseringspræparater og anvendelse deraf
EP1231218A3 (en) An appetite-suppressing peptide, its compositions and use
DK0883687T3 (da) C-C CKR-5, CC-chemokinreceptor, derivater deraf og anvendelse deraf
DK1187591T3 (da) IBD-associerede mikrobielle antigener og fremgangsmåder til at anvende samme
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
ATE196314T1 (de) Verfahren und zusammensetzungen zur verhinderung von entzündungen und angiogenese enthaltend säugetieren cd97 alpha untereinheit
DK1185691T3 (da) Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf
DK1203817T3 (da) Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
NO20060093L (no) Plate glykoprotein IB alfa-variant fusjonspolypeptider og fremgangsmater for anvendelse derav
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
ATE398630T1 (de) Zyklische conotoxin-peptide
WO1999045098A3 (en) Delivery or proteins into eukaryotic cells with recombinant yersinia
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
WO2003010291A3 (en) Treatment of immune disorders and b cell disorders
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
DK0781344T3 (da) Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
DK0863981T3 (da) Detektering, forebyggelse og behandling af papillomatous digital dermatitis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application